For Immediate Release Contact: Gary K. Bennett
May 31, 2001 (860-648-8004)

Gerber Scientific, Inc. Reports Fourth Quarter Results

SOUTH WINDSOR, CT -- Gerber Scientific, Inc. (NYSE: GRB) today reported financial results for the fourth quarter and fiscal year ended April 30, 2001. The Company highlighted the following:

Results

Strategic Actions

Outlook

Fourth Quarter Impacted by Global Economic Uncertainty, Strong Dollar

Before restructuring and other special charges, the Company reported a loss of $.04 per diluted share for the fourth quarter ended April 30, 2001 on sales of $137.5 million compared with earnings of $.26 per share for the fourth quarter of last year on sales of $162.9 million. The net loss in this year's fourth quarter was $0.8 million before restructuring and other special charges, compared with net earnings of $5.8 million for the same period last year. The restructuring and other special charges in this year's fourth quarter amounted to $18.3 million after taxes, or $.83 per share and resulted in a net loss per share for the quarter of $.87. Last year's fourth quarter included a charge for $4.1 million after taxes, or $.18 per share, and resulted in net earnings per share for that quarter of $.08.

For the fiscal year, the Company reported a loss per share of $.11 before restructuring and other special charges on sales of $553.0 million. After these charges, the net loss per share for the year ended April 30, 2001 was $1.07 (note that this amount also includes a first quarter special charge). These results compared with earnings of $1.34 per diluted share before a special charge for last year on sales of $610.7 million. Diluted earnings per share for last year were $1.16 after the charge. The net loss in this fiscal year was $2.5 million before the restructuring and other special charges and $23.6 million after the charges. Net earnings were $30.0 million for last year before special charges and $25.9 million after.

Commenting on the fourth quarter results, Michael J. Cheshire, Chairman and Chief Executive Officer, said, "Fourth quarter results reflect the weakness in demand for capital equipment in each of our business segments, especially in North America. Substantial cost reductions helped narrow the loss to $.04 per share (before restructuring and other special charges) in the quarter from a $.17 per share loss in the third quarter. Working capital continued to come down and we generated over $11.0 million in cash flow in the quarter. Debt reduction continues to be a top priority. Although we remain cautious about the near term outlook for our markets and the continued strength of the dollar, the restructuring initiatives will enable Gerber Scientific to return to profitability as a leaner, more focused company."

Actions to Reduce Debt

The Company reported that asset sales and improved working capital management in the fiscal year generated improved cash flow, despite lower operating results. Cash flow from operations amounted to $36.7 million for fiscal year 2001 compared with $27.1 million in the prior year. Reductions in the Company's working capital, particularly accounts receivable and inventory, contributed to this improvement. Asset sales added to cash generation, including approximately $12.0 million received from a sale/leaseback transaction involving the Bristol, UK facility of the Company's Spandex PLC subsidiary. The Company has reduced its debt by $25.0 million since the beginning of fiscal year 2001 and is focused on generating additional cash flow to further reduce its debt level. The Company remains committed to selling certain idle facilities and is negotiating an additional sale/leaseback transaction involving its principal South Windsor, Connecticut campus. The Company also announced on February 23, 2001 that its Board of Directors voted to suspend the $.08 quarterly dividend after the February 28, 2001 payment. Suspension of the dividend will provide the Company with an additional $7.0 million per year of cash flow to be used toward lowering debt.

Weaker Foreign Currencies Lower Results

As in previous periods, weaker year-to-year foreign currency exchange rates affected the Company's results in the fourth quarter and fiscal year ended April 30, 2001. Revenue for this year's fourth quarter of $137.5 million reflected a $6.2 million adverse impact from foreign currency translation rates on a year-to-year basis. Holding currency values constant with the prior year, the 2001 fiscal year's revenue of $553.0 million would have been $32.5 million higher, or $585.5 million. Earnings per share were $.01 lower in this year's fourth quarter due to weaker currency translation rates and were $.23 lower in the fiscal year.

Profit Margins Impacted by Lower Revenue and Sales Mix

Profitability continued to be impacted by top-line weakness in the Company's three core businesses. Each segment realized lower year-to-year sales in both the fourth quarter and fiscal year with the most significant declines in the Apparel and Flexible Materials segment. Profitability was off substantially on a year-to-year basis in the Company's two largest operating segments, Sign Making and Specialty Graphics and Apparel and Flexible Materials, and to a lesser extent in the Optical Lens Processing segment.

As was the case in prior quarters, profitability in this year's fourth quarter was also impacted by lower gross profit margins. The weaker foreign currency values lowered gross profit margins as did changes in the sales mix, which favored higher margin products last year. Additionally, the geographic shift of sales this year to international markets had an adverse impact on margins, as the Company generally sells through distributors and agents in those markets.

Orders Dampened by Market Weakness and Currency Effect on Competitiveness

New orders totaled $136.2 million for the three months ended April 30, 2001, compared with $148.3 million last year. For the fiscal year, new orders amounted to $548.2 million compared with $605.1 million last year. Each of the Company's operating segments reported lower orders in the current year, with shortfalls occurring in both the European and North American markets throughout the year. In addition, orders from other international markets declined in the fourth quarter. The relative strength of the U.S. dollar offered the Company's European competitors pricing advantages, particularly in that geographic market. Weakening economic conditions in North American markets also resulted in fewer orders, particularly for equipment. Currency weakness in certain international markets (including Turkey, Brazil, and Australia) slowed orders from those markets in the fourth quarter.

Backlog at the end of this fiscal year was $40.5 million compared with $45.2 million at the beginning of the year, with the decrease occurring primarily in the Sign Making and Specialty Graphics segment. Order entry in this segment was dampened by previously reported problems experienced in the introduction of the Gerber MAXX™, a new wide-format thermal imaging system. The Company has re-introduced MAXX units to the field in "beta" testing and has received satisfactory reports on the units' performance. However, the MAXX has not yet been released for full production and remains on technical hold.

Company Restructures Operations, Takes Charges

In the fourth quarter, the Company implemented plans to reduce worldwide employment by approximately 350 employees (13 percent of its workforce), discontinue product lines, and consolidate facilities as part of its overall strategic initiative to restructure operations and reduce costs. These actions were principally in the Apparel and Flexible Materials, and Sign Making and Specialty Graphics segments, although each of the Company's operating segments was affected. These plans were the result of difficult U.S. economic conditions, general global economic uncertainty, the prolonged weakness of the Euro currency, and problems experienced in the rollout of new products. The aggregate pre-tax restructuring and other special charges were $26.9 million: $1.1 million was included in revenue (as a write-off of receivables), $10.9 million in the cost of sales, $1.8 million in selling, general and administrative expenses, and $13.1 million as restructuring charges in the consolidated statement of earnings. The aggregate charge is comprised of employee separation costs, facility exit costs, inventory write-downs, impairments of long-lived assets (principally facilities), and other charges. The goal of the restructuring actions is to reduce operating costs by $30 to $35 million on an annual basis by fiscal year 2003.

Completed Review of Strategic Alternatives for Optical Business

The Company previously reported that it completed its review of strategic alternatives for its optical lens processing unit, Gerber Coburn. Based on an extensive review and discussions with potential strategic and financial parties, Gerber Scientific, Inc. determined that Gerber Coburn will remain a business segment of the Company.

Outlook: Uncertain Global Economic Environment; Results Expected to Improve in New Fiscal Year

Given current economic conditions, the Company anticipates limited top line growth in its new fiscal year 2002, which began May 1, 2001. As previously noted, the Company currently expects sales in the range of $560 to $565 million for fiscal year 2002, a modest increase from $553 million for the fiscal year just ended. Based largely on benefits derived from the cost reduction actions taken in fiscal year 2001, the Company currently anticipates earnings per share in the range of $.45 to $.50 next fiscal year.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is the world's leading supplier of sophisticated automated manufacturing systems that enable mass customization in sign making and specialty graphics, apparel and flexible goods, and optical lens processing. Headquartered in South Windsor, Connecticut, the Company operates through four wholly-owned subsidiaries: Gerber Scientific Products and Spandex PLC, Gerber Technology, and Gerber Coburn.

In addition to the historical information contained herein, there are matters discussed that are considered to be "forward looking statements." The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. These forward looking statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, and services, that could significantly affect results in the future. For a discussion of other risk factors relating to the Company's business, see the Company's Quarterly Reports on Form 10-Q for the quarters ended July 31, 2000, October 31, 2000, and January 31, 2001 and its Annual Report on Form 10-K for the year ended April 30, 2000, as filed with the Securities and Exchange Commission. The forward-looking statements contained in this release are made as of the date of this release, and the Company assumes no obligation to update or revise any forward-looking statements contained in this release.

 

Maxx is a trademark of Gerber Scientific Products

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED ANALYSIS OF EARNINGS

Comparison on a consolidated basis for the three months and fiscal years ended April 30, 2001 and 2000 follows:

FINANCIAL FIGURES FOR THREE MONTHS AND FISCAL YEARS ENDED APRIL 30, 2001 AND 2000

 

Fourth Quarter

 

Fiscal Year

 

2001

 

2000

 

2001

 

2000

               

Sales

$137,471,000 

 

$162,854,000 

 

$ 552,960,000 

 

$610,726,000 

 

==========

 

==========

 

==========

 

==========

               

Earnings (loss) before charges

$  (1,350,000)

 

$    8,618,000 

 

$   (1,121,000)

 

$ 45,175,000 

Restructuring and other special charges (1) (2)

(26,891,000)

 

(6,200,000)

 

(31,310,000)

 

(6,200,000)

 

                      

 

                      

 

                      

 

                      

Earnings (loss) before income taxes

$(28,241,000)

 

$    2,418,000 

 

$ (32,431,000)

 

$ 38,975,000 

 

                      

 

                      

 

                      

 

                      

               

Taxes on earnings before charges (3)

$     (500,000)

 

$    2,800,000 

 

$    1,400,000 

 

$ 15,200,000 

Tax benefit of charges

(8,600,000)

 

(2,100,000)

 

(10,200,000)

 

(2,100,000)

 

                      

 

                      

 

                      

 

                      

Provision (benefit) for income taxes

$  (9,100,000)

 

$       700,000 

 

$  (8,800,000)

 

$ 13,100,000 

 

                      

 

                      

 

                      

 

                      

               

Net earnings (loss) before charges

$     (850,000)

 

$   5,818,000 

 

$  (2,521,000)

 

$29,975,000 

Restructuring and other special charges,

    net of taxes (1)(2)


(18,291,000)

 


(4,100,000)

 


(21,110,000)

 


(4,100,000)

 

                      

 

                      

 

                      

 

                      

Net earnings (loss)

$(19,141,000)

 

$   1,718,000 

 

$(23,631,000)

 

$25,875,000 

 

==========

 

==========

 

==========

 

==========

Per share of common stock:

             

    Basic (4)

             

          Before charges

$             (.04)

 

$             .26 

 

$             (.11)

 

$           1.35 

          Restructuring and other special charges

(.83)

 

(.18)

 

(.96)

 

(.18)

 

                      

 

                      

 

                      

 

                      

 

$             (.87)

 

$             .08 

 

$           (1.07)

 

$           1.17 

 

==========

 

==========

 

==========

 

==========

     Diluted (4)

             

          Before charges

$             (.04)

 

$             .26 

 

$             (.11)

 

$           1.34 

          Restructuring and other special charges

(.83)

 

(.18)

 

(.96)

 

(.18)

 

                      

 

                      

 

                      

 

                      

 

$             (.87)

 

$             .08 

 

$           (1.07)

 

$           1.16 

 

==========

 

==========

 

==========

 

==========

Average shares outstanding:

             

     Basic

22,038,000 

 

22,059,000 

 

22,017,000 

 

22,140,000 

 

==========

 

==========

 

==========

 

==========

     Diluted

22,038,000 

 

22,209,000 

 

22,017,000 

 

22,390,000 

 

==========

 

==========

 

==========

 

==========

 

See notes on next page.

(1) Included in the fiscal year ended April 30, 2001 were restructuring and other special charges related to reductions in workforce, provisions for losses on the sale of facilities, inventory write-downs, impairments of long-lived assets, and other charges. These charges, recorded in the first and fourth quarters of the fiscal year, amounted to $31,310,000 before income taxes and $21,110,000 after taxes ($.96 per diluted share). Included in the first quarter ended July 31, 2000 were restructuring charges that amounted to $4,419,000 before income taxes and $2,819,000 after taxes ($.13 per diluted share) and in the fourth quarter ended April 30, 2001 restructuring and other special charges that amounted to $26,891,000 before income taxes and $18,291,000 after taxes ($.83 per diluted share).

(2) Included in the three and twelve months ended April 30, 2000 was a charge recorded for excess costs caused by cost overruns and inefficiencies realized in the initial production runs of products introduced in that year. This charge was included in the cost of product sales and amounted to $6,200,000 before income taxes and $4,100,000 after taxes ($.18 per diluted share).

(3) The income tax expense associated with the loss before charges in the fiscal year ended April 30, 2001 arose principally from the non-deductibility of goodwill amortization.

(4) Earnings per share information was computed separately for each period. Therefore, the sum of such quarterly share amounts may differ from the total for the year.

 

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS

 

Three Months Ended
April 30,

In thousands (except per share amounts)

2001 

 

2000 

       

Revenue:

     

     Product sales

$125,914 

 

$149,534 

     Service

 11,557 

 

13,320 

 

               

 

               

 

 137,471 

 

162,854 

 

               

 

               

Costs and Expenses:

     

     Cost of product sales

93,075 

 

100,194 

     Cost of service

9,426 

 

7,146 

     Selling, general and administrative

37,693 

 

39,633 

     Research and development expenses

 6,746 

 

8,138 

     Goodwill amortization

 2,230 

 

2,286 

     Restructuring charge

 13,120 

 

--- 

 

               

 

               

 

 162,290 

 

157,397 

 

               

 

               

Operating income (loss)

(24,819)

 

5,457 

       

Other income (expense)

 (201)

 

(26)

Interest expense

(3,221)

 

(3,013)

 

               

 

               

       

Earnings (loss) before income taxes(1)

(28,241)

 

2,418 

Provision (benefit) for income taxes

(9,100)

 

700 

 

               

 

               

Net earnings (loss) (1)

$(19,141)

 

$    1,718 

 

=======

 

=======

Per share of common stock: (1)

     

     Basic

$     (.87)

 

$        .08 

     Diluted

$     (.87)

 

$        .08 

       

     Dividends

$      .08 

 

$        .08 

       

Average shares outstanding:

     

     Basic

22,038 

 

22,059 

     Diluted

22,038 

 

22,209 

(1) Included in the fourth quarter ended April 30, 2001 were restructuring and other special charges related to reductions in workforce, provisions for losses on the sale of facilities, inventory write-downs, impairments of long-lived assets, and other charges. These charges amounted to $26,891,000 before income taxes and $18,291,000 after taxes ($.83 per diluted share).

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS

 

Fiscal Year Ended
April 30,

In thousands (except per share amounts)

2001 

 

2000 

       

Revenue:

     

     Product sales

$504,391 

 

$556,985 

     Service

 48,569 

 

53,741 

 

               

 

               

 

 552,960 

 

610,726 

 

               

 

               

Costs and Expenses:

     

     Cost of product sales

336,406 

 

340,143 

     Cost of service

33,761 

 

28,719 

     Selling, general and administrative

146,399 

 

151,701 

     Research and development expenses

29,272 

 

33,022 

     Goodwill amortization

8,943 

 

8,639 

     Restructuring charges

17,539 

 

--- 

 

               

 

               

 

 572,320 

 

562,224 

 

               

 

               

       

Operating income (loss)

(19,360)

 

48,502 

       

Other income

 194 

 

1,090 

Interest expense

(13,265)

 

(10,617)

 

               

 

               

       

Earnings (loss) before income taxes(1)

(32,431)

 

38,975 

Provision (benefit) for income taxes

(8,800)

 

13,100 

 

               

 

               

Net earnings (loss) (1)

$ (23,631)

 

$  25,875 

 

=======

 

=======

Per share of common stock: (1)

     

     Basic

$    (1.07)

 

$      1.17 

     Diluted

$    (1.07)

 

$      1.16 

       

     Dividends

$       .32 

 

$        .32 

       

Average shares outstanding:

     

     Basic

22,017 

 

22,140 

     Diluted

22,017 

 

22,390 

(1) Included in the fiscal year ended April 30, 2001 were restructuring and other special charges related to reductions in workforce, provisions for losses on the sale of facilities, inventory write-downs, impairments of long-lived assets, and other charges. These charges, recorded in the first and fourth quarters of the fiscal year, amounted to $31,310,000 before income taxes and $21,110,000 after taxes ($.96 per share on a diluted basis.) Included in the first quarter ended July 31, 2001 were restructuring charges that amounted to $4,419,000 before income taxes and $2,819,000 after taxes ($.13 per diluted share) and in the fourth quarter ended April 30, 2001 restructuring and other special charges that amounted to $26,891,000 before income taxes and $18,291,000 after taxes ($.83 per diluted share).

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS


In thousands

April 30, 2001

 

April 30, 2000

Assets:

     

Current Assets:

     

     Cash and short-term cash investments

$20,866 

 

$  22,954 

     Accounts receivable

98,159 

 

121,494 

     Inventories

69,441 

 

86,472 

     Prepaid expenses

18,965 

 

21,042 

     Net assets held for sale

21,369 

 

--- 

               

               

 

228,800 

 

251,962 

 

               

 

               

Property, Plant and Equipment:

112,572 

 

165,341 

     Less accumulated depreciation

53,022 

 

66,121 

 

               

 

               

 

59,550 

 

99,220 

 

               

 

               

Intangible Assets:

243,669 

 

245,797 

     Less accumulated amortization

36,112 

 

27,419 

 

               

 

               

 

207,557 

 

218,378 

 

               

 

               

Deferred Income Taxes:

793 

 

--- 

Other Assets:

4,493 

 

3,276 

 

               

 

               

 

$501,193 

 

$572,836 

 

=======

 

=======

Liabilities and Shareholders' Equity:

     

Current Liabilities:

     

     Notes payable

$        --- 

 

$        --- 

     Accounts payable

48,520 

 

58,043 

     Accrued compensation and benefits

18,576 

 

16,646 

     Other accrued liabilities

25,749 

 

26,689 

     Deferred revenue

13,129 

 

8,436 

     Advances on sales contracts

1,562 

 

2,610 

 

               

 

               

 

107,536 

 

112,424 

 

               

 

               

Noncurrent Liabilities:

     

     Deferred income taxes

--- 

 

8,608 

     Long-term debt

169,914 

 

194,892 

 

               

 

               

 

169,914 

 

203,500 

 

               

 

               

 

Contingencies and Commitments:

     

Shareholders' Equity:

     

     Preferred stock, no par value; authorized 10,000,000          shares; no shares issued


--- 

 


--- 

     Common stock, $1.00 par value; authorized 65,000,000          shares; issued 22,828,742 and 22,779,651 shares


 22,829 

 


22,780 

     Paid-in capital

 43,835 

 

43,615 

     Retained earnings

 180,082 

 

210,749 

     Treasury stock, at cost (784,837 and 797,444 shares,          respectively)

(16,138)

 

(16,397)

     Unamortized value of restricted stock grants

(439)

 

(557)

     Accumulated other comprehensive income (loss)

(6,426)

 

(3,278)

 

               

 

               

 

223,743 

 

256,912 

 

               

 

               

 

$501,193 

 

$572,836 

 

=======

 

=======

 

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Fiscal Year Ended
April 30,

In thousands

2001 

 

2000 

Cash Provided by (Used for):

Operating Activities:

     

     Net earnings (loss)

$(23,631)

 

$25,875 

     Adjustments to reconcile net earnings (loss)
        to cash provided by operating activities:

     

          Depreciation and amortization

27,228 

 

25,622 

          Special charges

31,310 

 

--- 

          Deferred income taxes

(9,401)

 

(1,613)

          Other non-cash items

533 

 

460 

          Changes in operating accounts, net of
            effects of business acquisitions:

     

           Receivables

22,319 

 

(13,980)

           Inventories

6,205 

 

(8,463)

           Prepaid expenses

 1,963 

 

6,044 

           Accounts payable and accrued expenses

(19,796)

 

(6,855)

                 

                 

Provided by Operating Activities

36,730 

 

27,090 

                 

                 

Investing Activities:

     

     Additions to property, plant and equipment

(14,757)

 

(22,313)

     Proceeds from sale of assets

13,721 

 

--- 

     Business acquisitions

--- 

 

(14,744)

     Intangible and other assets

(1,982)

 

(189)

     Other, net

(3,148)

 

(4,491)

                 

                 

(Used for) Investing Activities

(6,166)

 

(41,737)

                 

                 

Financing Activities:

     

     Purchase of common stock

--- 

 

(4,701)

     Additions of long-term debt

47,000 

 

74,566 

     Repayments of long-term debt

(71,978)

 

(53,205)

     Net short-term financing

--- 

 

(1,798)

     Debt issue costs

(751)

 

--- 

     Proceeds from issuance of stock

113 

 

3,305 

     Dividends on common stock

(7,036)

 

(7,089)

                 

                 

Provided by (Used for) Financing Activities

(32,652)

 

11,078 

                 

                 

(Decrease) in Cash and Short-Term Cash Investments

(2,088)

 

(3,569)

Cash and Short-Term Cash Investments, Beginning of Year

22,954 

 

26,523 

                 

                 

Cash and Short-Term Cash Investments, End of Year

$20,866 

 

$22,954 

======

======